Mirum Pharmaceuticals (MIRM) Leases (2020 - 2025)
Historic Leases for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to $8.5 million.
- Mirum Pharmaceuticals' Leases fell 695.13% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year decrease of 695.13%. This contributed to the annual value of $8.7 million for FY2024, which is 57562.31% up from last year.
- Mirum Pharmaceuticals' Leases amounted to $8.5 million in Q3 2025, which was down 695.13% from $8.9 million recorded in Q2 2025.
- In the past 5 years, Mirum Pharmaceuticals' Leases registered a high of $9.1 million during Q3 2024, and its lowest value of $300000.0 during Q2 2022.
- Over the past 5 years, Mirum Pharmaceuticals' median Leases value was $1.6 million (recorded in 2023), while the average stood at $3.7 million.
- Its Leases has fluctuated over the past 5 years, first tumbled by 8333.33% in 2022, then skyrocketed by 102691.18% in 2025.
- Mirum Pharmaceuticals' Leases (Quarter) stood at $1.6 million in 2021, then decreased by 8.8% to $1.4 million in 2022, then dropped by 10.27% to $1.3 million in 2023, then soared by 575.62% to $8.7 million in 2024, then dropped by 2.02% to $8.5 million in 2025.
- Its Leases stands at $8.5 million for Q3 2025, versus $8.9 million for Q2 2025 and $7.7 million for Q1 2025.